http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
22nd Century Group (XXII) Appoints R. Hugh Kinsman as CFO
-
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
-
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
-
22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
-
22nd Century Group (XXII) Appoints John J. Miller to Its Tobacco Business
-
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
-
22nd Century Group (XXII) Begins Integration of GVB Biopharma
-
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
-
22nd Century Group (XXII) Acquires GVB Biopharma
-
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
-
22nd Century Group (XXII) Reports Q1 Revenue of $9M, EPS of ($0.05), Provides Business Highlights
-
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
-
22nd Century Group (XXII) Expects VLN Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
-
22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
-
22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
-
22nd Century Group (XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
-
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
-
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
-
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
-
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
-
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
-
22nd Century Group (XXII) Appoints Calvin Treat as Chief Scientific Officer
-
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
-
22nd Century Group (XXII) Announces Reduced-Nicotine Cigarette That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
-
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
-
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
-
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
-
22nd Century Group (XXII) Announces South Korea as First VLN International Market
-
22nd Century Group Announces South Korea as First VLN® International Market
-
22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes
-
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
-
22nd Century Group (XXII) Secures USDA Organic Certification for Needle Rock Farms
-
22nd Century Secures USDA Organic Certification for Needle Rock Farms
-
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
-
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
-
22nd Century Group (XXII) Announces First Production of VLN® Cigarettes for Retail Sale
-
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
-
22nd Century Group (XXII) Appoints James A. Mish to Its Board
-
22nd Century Group Appoints James A. Mish to Its Board of Directors
-
22nd Century Group (XXII) Says it's Launching First Reduced Nicotine Cigarette Authorized by FDA That Helps You Smoke Less
-
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
-
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
-
22nd Century Group (XXII) Granted FDA Approval for VLN as a Modified Risk Tobacco Product
-
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
-
22nd Century Group (XXII) Confirms FDA Authorizes Marketing of its VLN as Modified Risk Tobacco Product
-
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
-
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
-
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
